Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). [electronic resource]
Producer: 20090608Description: 203-9 p. digitalISSN:- 1750-2659
- Administration, Intranasal
- Antibodies, Viral -- blood
- Cross Reactions
- Hemagglutination Inhibition Tests
- Humans
- Immunization, Secondary
- Immunoglobulin A -- analysis
- Influenza A Virus, H2N2 Subtype -- genetics
- Influenza A Virus, H5N1 Subtype -- immunology
- Influenza A Virus, H5N2 Subtype -- genetics
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Nasal Mucosa -- immunology
- Neutralization Tests
- Reassortant Viruses -- genetics
- Russia
- Vaccines, Attenuated -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.